Panobinostat的封面
书籍主题:

Panobinostat

Betascript Publishing (2010-09-09 )

Books loader

Omni badge 有获得代金券的资格
ISBN-13:

978-613-2-94314-9

ISBN-10:
6132943145
EAN:
9786132943149
书籍语言:
英文
作品简介:
Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. Panobinostat (LBH-589) is an experimental drug developed by Novartis for the treatment of cancer. As of December 2008, it is being tested against cutaneous T cell lymphoma (CTCL), chronic myelogenous leukemia, myelodysplastic syndromes, breast cancer, prostate cancer and other types of malignant disease in a number of Phase II and III clinical trials, for example a Phase III study for CTCLPanobinostat has been found to synergistically act with sirolimus to kill pancreatic cancer cells in the laboratory in a Mayo Clinic study. In the study, investigators found that this combination destroyed up to 65 percent of cultured pancreatic tumor cells. The finding is significant because the three cell lines studies were all resistant to the effects of chemotherapy – as are many pancreatic tumors.[
出版社 :
Betascript Publishing
网址:
https://www.betascript-publishing.com/
出版发行由:
Lambert M. Surhone, Mariam T. Tennoe, Susan F. Henssonow
页码 :
124
发表日期:
2010-09-09
现货:
备有现货
类别:
医学
价格:
39.00 €
关键词:
drug, Novartis, Cutaneous T cell Lymphoma

Books loader

Adyen::diners Adyen::jcb Adyen::discover Adyen::amex Adyen::mc Adyen::visa Adyen::cup Adyen::ach Adyen::wechatpay Adyen::unionpay Paypal 银行转帐

LOGIN
  0产品在购物车内
编辑购物车
Loading frontend
LOADING